Demographics and response to therapeutic plasma exchange in pediatric renal transplantation for focal glomerulosclerosis: A single center experience

Pediatric Transplantation

Volumn 12, Issue 6, 2008, Pages 682-688

  Mahesh, Shefali ^b   Del Rio, Marcela ^b   Feuerstein, Dianne ^a   Greenstein, Stuart ^a   Schechner, Richard ^a   Tellis, Vivian ^a   Kaskel, Frederick ^a,b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

Author keywords

Children; Focal glomerulosclerosis; Recurrence; Renal transplantation; Therapeutic plasma exchange

Indexed keywords

CREATININE;

ADOLESCENT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; DEMOGRAPHY; FOCAL GLOMERULOSCLEROSIS; GRAFT SURVIVAL; HUMAN; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVING DONOR; PLASMAPHERESIS; PREOPERATIVE PERIOD; PROTEINURIA; RECURRENCE RISK; REMISSION; TREATMENT INDICATION; TREATMENT RESPONSE;

BIOPSY; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; PLASMA EXCHANGE; RECURRENCE; TREATMENT OUTCOME;

EID: 49349106248     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00880.x     Document Type: Article

References (24)

1. Benfield MR, McDonald R, Sullivan EK, Stablein DM, Tejani A. The 1997 annual renal transplantation in children report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1999: 3: 152 167.
2. Baum MA, Stablein DM, Panzarino VM, Tejani A, Harmon WE, Alexander SR. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001: 59: 328 333.
3. Tejani A, Stablein DH. Recurrence of focal segmental glomerulosclerosis posttransplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1992: 2 (Suppl. S258 S263.
4. Fujisawa M, Iijima K, Ishimura T, et al. Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation. Pediatr Nephrol 2002: 17: 165 168.
5. Hubsch H, Montane B, Abitbol C, et al. Recurrent focal glomerulosclerosis in pediatric renal allografts: The Miami experience. Pediatr Nephrol 2005: 20: 210 216.
6. Baum MA. Outcomes after renal transplantation for FSGS in children. Pediatr Transplant 2004: 8: 329 333.
7. Sharma M, Sharma R, McCarthy ET, Savin VJ. The focal segmental glomerulosclerosis permeability factor: Biochemical characteristics and biological effects. Exp Biol Med (Maywood) 2004: 229: 85 98.
8. Sharma M, Sharma R, Reddy SR, McCarthy ET, Savin VJ. Proteinuria after injection of human focal segmental glomerulosclerosis factor. Transplantation 2002: 73: 366 372.
9. Greenstein SM, DelRio M, Ong E, et al. Plasmapheresis treatment for recurrent focal sclerosis in pediatric renal allografts. Pediatr Nephrol 2000: 14: 1061 1065.
10. Ohta T, Kawaguchi H, Hattori M, et al. Effect of pre- and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation 2001: 71: 628 633.
11. Newstead CG. Recurrent disease in renal transplants. Nephrol Dial Transplant 2003: 18 (Suppl. 6 vi68 vi74.
12. Gohh RY, Yango AF, Morrissey PE, et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 2005: 5: 2907 2912.
13. Cibrik DM, Kaplan B, Campbell DA, Meier-Kriesche HU. Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis. Am J Transplant 2003: 3: 64 714.
14. Weber S, Tonshoff B. Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: Clinical and genetic aspects. Transplantation 2005: 80 (Suppl. S128 S134.
15. Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996: 334: 878 883.
16. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994: 23: 574 581.
17. Odorico JS, Knechtle SJ, Rayhill SC, et al. The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 1996: 61: 228 234.
18. Yarimizu SN, Susan LP, Straffon RA, Stewart BH, Magnusson MO, Nakamoto SS. Mortality and morbidity in pretransplant bilateral nephrectomy: Analysis of 305 cases. Urology 1978: 12: 55 58.
19. Ingulli E, Tejani A. Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children - A single-center experience. Transplantation 1991: 51: 401 405.
20. Salomon R, Gagnadoux MF, Niaudet P. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 2003: 75: 810 814.
21. McCauley J, Shapiro R, Jordan M, et al. FK 506 in the management of nephrotic syndrome after renal transplantation. Transplant Proc 1993: 25 (Pt. 2 1351 1354.
22. Briggs WA, Choi MJ, Scheel PJ Jr. Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis 1998: 31: 213 217.
23. Pescovitz MD, Book BK, Sidner RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 2006: 354: 1961 1963.
24. Kamar N, Faguer S, Esposito L, et al. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. Clin Nephrol 2007: 67: 250 254.